- Home
- STRO vs RGS Comparison
STRO vs RGS Comparison
Compare STRO & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- RGS
- Stock Information
- Founded
- STRO 2003
- RGS 1922
- Country
- STRO United States
- RGS United States
- Employees
- STRO N/A
- RGS N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- RGS Other Consumer Services
- Sector
- STRO Health Care
- RGS Consumer Discretionary
- Exchange
- STRO Nasdaq
- RGS Nasdaq
- Market Cap
- STRO 50.0M
- RGS 44.6M
- IPO Year
- STRO 2018
- RGS 1991
- Fundamental
- Price
- STRO $0.87
- RGS $19.11
- Analyst Decision
- STRO Hold
- RGS
- Analyst Count
- STRO 8
- RGS 0
- Target Price
- STRO $6.14
- RGS N/A
- AVG Volume (30 Days)
- STRO 2.3M
- RGS 7.8K
- Earning Date
- STRO 05-08-2025
- RGS 05-13-2025
- Dividend Yield
- STRO N/A
- RGS N/A
- EPS Growth
- STRO N/A
- RGS N/A
- EPS
- STRO N/A
- RGS 40.46
- Revenue
- STRO $62,043,000.00
- RGS $191,336,000.00
- Revenue This Year
- STRO N/A
- RGS N/A
- Revenue Next Year
- STRO $1.29
- RGS N/A
- P/E Ratio
- STRO N/A
- RGS $0.52
- Revenue Growth
- STRO N/A
- RGS N/A
- 52 Week Low
- STRO $0.52
- RGS $3.87
- 52 Week High
- STRO $5.17
- RGS $35.50
- Technical
- Relative Strength Index (RSI)
- STRO 48.53
- RGS 55.42
- Support Level
- STRO $0.80
- RGS $17.50
- Resistance Level
- STRO $1.11
- RGS $19.60
- Average True Range (ATR)
- STRO 0.18
- RGS 1.02
- MACD
- STRO 0.02
- RGS 0.16
- Stochastic Oscillator
- STRO 41.53
- RGS 82.10
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.